|
|
|
|
pmid:28302565
|
|
|
|
|
pmid:28189120
|
|
|
|
|
pmid:25190453
|
|
|
|
|
pmid:25184787
|
|
|
|
|
pmid:25181418
|
|
|
|
|
pmid:27256330
|
|
|
|
|
pmid:27255234
|
|
|
|
|
pmid:26447026
|
|
|
|
|
pmid:24975835
|
|
|
|
|
pmid:24948035
|
|
|
|
|
pmid:26923849
|
|
|
|
|
pmid:26909563
|
|
|
|
|
pmid:24697526
|
|
|
|
|
pmid:24689950
|
|
|
|
|
pmid:26584851
|
|
|
|
|
pmid:26581047
|
|
|
|
|
pmid:24249810
|
|
|
|
|
pmid:24212399
|
|
|
|
|
pmid:26362186
|
|
|
|
|
pmid:26361088
|
|
|
|
|
pmid:26112994
|
|
|
|
|
pmid:26099662
|
|
|
|
|
pmid:25866993
|
|
|
|
|
pmid:25865548
|
|
|
|
|
pmid:28260080
|
|
|
|
|
pmid:28259984
|
|
|
|
|
pmid:25643339
|
|
|
|
|
pmid:25634035
|
|
|
|
|
pmid:27849387
|
|
|
|
|
pmid:27845067
|
|
|
|
|
pmid:25446166
|
|
|
|
|
pmid:25442456
|
|
|
|
|
pmid:27664484
|
|
|
|
|
pmid:27663616
|
Wang Y et al. |
Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. |
|
Phytomedicine |
pmid:24854571
|
|
|
|
|
pmid:12354528
|
|
|
|
|
pmid:
|
Yamamoto N et al. |
Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. |
|
Prostaglandins Other Lipid Mediat. |
pmid:25677506
|
Hofbauer LC and Heufelder AE |
Osteoprotegerin: a novel local player in bone metabolism. |
1997 |
Eur. J. Endocrinol. |
pmid:9368500
|
Simonet WS et al. |
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. |
1997 |
Cell |
pmid:9108485
|
Kwon BS et al. |
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. |
1998 |
FASEB J. |
pmid:9657524
|
Yasuda H et al. |
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. |
1998 |
Endocrinology |
pmid:9492069
|
Hofbauer LC et al. |
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9784422
|
Matsuzaki K et al. |
Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9600092
|
Miyamoto A et al. |
Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9464281
|
Takai H et al. |
Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. |
1998 |
J. Biol. Chem. |
pmid:9765225
|
Lacey DL et al. |
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. |
1998 |
Cell |
pmid:9568710
|
Tomoyasu A et al. |
Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9571159
|
Bucay N et al. |
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. |
1998 |
Genes Dev. |
pmid:9573043
|
Yamaguchi K et al. |
Characterization of structural domains of human osteoclastogenesis inhibitory factor. |
1998 |
J. Biol. Chem. |
pmid:9478964
|
Yasuda H et al. |
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9520411
|
Schinke T et al. |
Molecular determinants of arterial calcification. |
1998 |
Ann. Med. |
pmid:9920355
|
Akatsu T et al. |
Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9753612
|
Hakeda Y et al. |
Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9790989
|
Horwood NJ et al. |
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. |
1998 |
Endocrinology |
pmid:9794488
|
Vidal NO et al. |
Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. |
1998 |
J. Endocrinol. |
pmid:9795357
|
Filvaroff E and Derynck R |
Bone remodelling: a signalling system for osteoclast regulation. |
1998 |
Curr. Biol. |
pmid:9768352
|
Akatsu T et al. |
Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. |
1998 |
Bone |
pmid:9855457
|
Morinaga T et al. |
Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor. |
1998 |
Eur. J. Biochem. |
pmid:9688283
|
Emery JG et al. |
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. |
1998 |
J. Biol. Chem. |
pmid:9603945
|
Tsukii K et al. |
Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9610359
|
Mizuno A et al. |
Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. |
1998 |
Gene |
pmid:9714833
|
Mizuno A et al. |
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9647741
|
Tsuda E and Higashio K |
[Osteoclastogenesis inhibitory factor (OCIF)/OPG]. |
1998 |
Nippon Rinsho |
pmid:9648461
|
Yamamoto M et al. |
Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. |
1998 |
Endocrinology |
pmid:9724059
|
Hofbauer LC and Heufelder AE |
Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. |
1998 |
Eur. J. Endocrinol. |
pmid:9724069
|
Brändström H et al. |
Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703945
|
Vidal ON et al. |
Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9703989
|
Brändström H et al. |
Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9642127
|
Yun TJ et al. |
OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. |
1998 |
J. Immunol. |
pmid:9834095
|
Murakami T et al. |
Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9837778
|
Kong YY et al. |
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. |
1999 |
Nature |
pmid:10580503
|
Spelsberg TC et al. |
The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. |
1999 |
Mol. Endocrinol. |
pmid:10379881
|
Burgess TL et al. |
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. |
1999 |
J. Cell Biol. |
pmid:10225954
|
Nagai M and Sato N |
Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10208850
|
Hsu H et al. |
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10097072
|
Shalhoub V et al. |
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. |
1999 |
J. Cell. Biochem. |
pmid:10022507
|
Hofbauer LC et al. |
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. |
1999 |
Endocrinology |
pmid:10499489
|
Thomas RJ et al. |
Breast cancer cells interact with osteoblasts to support osteoclast formation. |
1999 |
Endocrinology |
pmid:10499498
|
Hofbauer LC |
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. |
1999 |
Eur. J. Endocrinol. |
pmid:10474114
|
Wickelgren I |
Mining the genome for drugs. |
1999 |
Science |
pmid:10475849
|
Hofbauer LC et al. |
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. |
1999 |
Endocrinology |
pmid:10465311
|
Morony S et al. |
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. |
1999 |
J. Bone Miner. Res. |
pmid:10469275
|
Sakata M et al. |
Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. |
1999 |
J. Bone Miner. Res. |
pmid:10469276
|
Lazner F et al. |
Osteopetrosis and osteoporosis: two sides of the same coin. |
1999 |
Hum. Mol. Genet. |
pmid:10469835
|
Itonaga I et al. |
1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10529407
|
Nakagawa N et al. |
Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10548488
|
Nakagawa N et al. |
Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10548507
|
Lee SK and Lorenzo JA |
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. |
1999 |
Endocrinology |
pmid:10433211
|
Ito H et al. |
Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10462495
|
Yasuda H et al. |
A novel molecular mechanism modulating osteoclast differentiation and function. |
1999 |
Bone |
pmid:10423033
|
Roodman GD |
Cell biology of the osteoclast. |
1999 |
Exp. Hematol. |
pmid:10428500
|
Zhang XD et al. |
Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. |
1999 |
Cancer Res. |
pmid:10364001
|
Kong YY et al. |
Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. |
1999 |
Immunol. Cell Biol. |
pmid:10234557
|
Yano K et al. |
Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. |
1999 |
J. Bone Miner. Res. |
pmid:10234572
|
Kanematsu M et al. |
[Effects of gravity on the gene expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor]. |
1999 |
Biol. Sci. Space |
pmid:12532992
|
Hofbauer LC et al. |
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. |
2000 |
J. Bone Miner. Res. |
pmid:10646108
|
Kanzawa M et al. |
Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. |
2000 |
Eur. J. Endocrinol. |
pmid:10822231
|
Quinn JM et al. |
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. |
2000 |
J. Bone Miner. Res. |
pmid:10934644
|
Min H et al. |
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. |
2000 |
J. Exp. Med. |
pmid:10952716
|